Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
about
Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibilityGermline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancerCadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunityThe metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factorBRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membraneRrp1b, a new candidate susceptibility gene for breast cancer progression and metastasisPolymorphisms of the SIPA1 gene and sporadic breast cancer susceptibilityMap making in the 21st century: charting breast cancer susceptibility pathways in rodent models.Fine-mapping QTLs in advanced intercross lines and other outbred populations.Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.Understanding susceptibility to breast cancer metastasis: the genetic approach.Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis.Genomics screens for metastasis genesAllelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis.CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma.Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma.Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.Genetic background may contribute to PAM50 gene expression breast cancer subtype assignmentsLessons in signaling and tumorigenesis from polyomavirus middle T antigen.Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix.Integrated cross-species transcriptional network analysis of metastatic susceptibility.Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulationMetastasis predictive signature profiles pre-exist in normal tissues.The Circadian Rhythm Gene Arntl2 Is a Metastasis Susceptibility Gene for Estrogen Receptor-Negative Breast Cancer.Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential.A systems biology approach to defining metastatic biomarkers and signaling pathwaysMetastasis: recent discoveries and novel treatment strategies.Genetically engineered mouse models in cancer researchNecdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.Bromodomain 4 activation predicts breast cancer survivalThe role of single nucleotide polymorphisms in breast cancer metastasis.The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survivalModels, mechanisms and clinical evidence for cancer dormancy.The origins of breast cancer prognostic gene expression profilesGenome-wide discovery of functional transcription factor binding sites by comparative genomics: the case of Stat3.Multimodality therapy: bone-targeted radioisotope therapy of prostate cancerGenetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival.Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival
P2860
Q21184029-0CB5AF48-7EAC-4A42-B3D2-5887C38AE494Q21195235-33EC3F43-453A-4846-8A54-BEAD8A9AA9D5Q27331937-4D69906B-E47F-4CEB-9540-3D8D650B319AQ28508523-1696F65E-B58E-4A08-89D9-8B8CDD59293DQ28535279-9964C506-AC74-4EAA-873D-CCCAEC69D0F5Q33310470-E3A86A48-AD48-45FD-957F-1E2FB9AEB721Q33504863-678DD2C0-1B36-462F-8955-2E4909FCE83BQ33908246-CF6FAB85-17D6-4062-A6B4-413A9781FA9DQ34019187-E6CFA26D-EAD9-42B5-8C83-18AC585DC574Q34038369-210B3591-F6AF-45CE-8354-D12702296251Q34149305-74B11D42-B62C-4FD0-A390-E394F16805FDQ34182453-37E5ACCB-8AA8-4662-9A3D-C85B3E450F8BQ34298860-1C80EE40-8022-4126-845D-A8C04DC96F1DQ34302171-F2110E59-6BAA-480E-8690-F7484A624EC1Q34586307-F549F7E6-0606-4F2F-AD4A-2AF69139F1ADQ34609220-8EB67865-D9C6-4FB4-A2F3-3EE595311C24Q34689297-A64D75E8-9988-4839-8370-B2B3BF9C4AC4Q34803675-ACE6DB1D-BCFF-496A-9911-02A42F2F9DF3Q34887726-7B649B20-346D-4D2B-A091-F4EBB94260E1Q34981442-2ADB7CC6-07BF-4A48-984F-3349F1B44646Q35000523-E8EC1680-0BE4-403F-9CB2-BD719E7A0391Q35684573-24E08D62-2A4F-4259-9789-8227C0217551Q35779338-33BE3129-7999-4AC4-B064-828C796FC536Q36050683-70A11F0C-B5EE-497E-AFC8-2E0A6DEAF138Q36103292-78AC8E0A-0A92-41F4-ADFE-09B320430428Q36140493-0AC0555B-0C7F-4D53-B29B-4654E6E356D2Q36174845-8D57980E-11E3-4A58-9D2C-83AC8D806EE4Q36199602-9F0FCCBC-D189-4224-8EC6-170284311C1EQ36407511-D65B692D-B112-453D-8D39-18EAE457F0E9Q36497718-3C4546F4-5B37-40F6-91A0-55FE86C5C1F1Q36544627-6C32B171-F8AE-49F7-AA55-48756F7CA594Q36609000-835DE319-3262-49CF-AD49-7504196EA801Q36643008-32930B7F-7989-4DA3-A931-A4F368DE96E5Q36696198-48F244BE-8B63-4C5D-A39B-9C511BE96410Q36844303-0091D537-E223-4A9C-813D-FFE0A7D45D2EQ37036319-0F5543A9-675C-4637-90CE-4E006C3EC29FQ37146867-9F68884C-30AC-40BA-8E8A-DDE22EB30F5BQ37193613-4C56657E-FE3F-4907-8617-E95B9E281C99Q37270155-F2C46E39-31F5-4CB4-9ECB-1BDE7907F860Q37284740-BDC22D55-C603-463B-B98B-96F8BEBF8076
P2860
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
@ast
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
@en
type
label
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
@ast
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
@en
prefLabel
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
@ast
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
@en
P2093
P2860
P356
P1433
P1476
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
@en
P2093
Douglas R Lowy
Kent W Hunter
Mindy Lancaster
Xiaohong Zhao
Xiaolan Qian
Yeong-Gwan Park
P2860
P2888
P304
P356
10.1038/NG1635
P407
P577
2005-09-04T00:00:00Z